Source: PR Newswire

Press Release: Amniox Medical : One-year Follow-up Study Results Find Cryopreserved Umbilical Cord Allograft for Treatment of Wagner Grade 3-4 Diabetic Foot Ulcers to be Safe with Higher than Expected Rates of Healing

MIAMI, June 1, 2020 /PRNewswire/ -- Amniox Medical, Inc. (Amniox), a TissueTech, Inc. company and pioneer in the clinical application of human birth tissue-based products, announced today the results from the one-year follow-up study to their Phase 2 open label, multicenter pilot study of...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Amy Tseng's photo - President & CEO of Amniox Medical

President & CEO

Amy Tseng

CEO Approval Rating

86/100

Read more